261 related articles for article (PubMed ID: 19835841)
1. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
Fuchs D; Heinold A; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2009 Dec; 390(3):743-9. PubMed ID: 19835841
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin in cancer: A new mission for an old agent.
Naujokat C; Fuchs D; Opelz G
Mol Med Rep; 2010; 3(4):555-9. PubMed ID: 21472278
[TBL] [Abstract][Full Text] [Related]
3. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.
Riccioni R; Dupuis ML; Bernabei M; Petrucci E; Pasquini L; Mariani G; Cianfriglia M; Testa U
Blood Cells Mol Dis; 2010 Jun; 45(1):86-92. PubMed ID: 20444629
[TBL] [Abstract][Full Text] [Related]
4. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells.
Zhang C; Tian Y; Song F; Fu C; Han B; Wang Y
Oncol Rep; 2015 Nov; 34(5):2469-76. PubMed ID: 26352531
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin: a new cancer drug candidate.
Huczynski A
Chem Biol Drug Des; 2012 Mar; 79(3):235-8. PubMed ID: 22145602
[TBL] [Abstract][Full Text] [Related]
8. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
9. Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo.
Wu D; Zhang Y; Huang J; Fan Z; Shi F; Wang S
Biochem Biophys Res Commun; 2014 Jan; 443(2):712-7. PubMed ID: 24333874
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin simultaneously induces apoptosis and autophagy through generation of reactive oxygen species in osteosarcoma U2OS cells.
Kim SH; Choi YJ; Kim KY; Yu SN; Seo YK; Chun SS; Noh KT; Suh JT; Ahn SC
Biochem Biophys Res Commun; 2016 Apr; 473(2):607-13. PubMed ID: 27033598
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells.
Li X; Zhang Y; Xiong C; Jin H; Jing B; Zhang Y; Fan D
Cancer Invest; 2009 Feb; 27(2):129-39. PubMed ID: 19235584
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.
Manmuan S; Sakunrangsit N; Ketchart W
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1042-1052. PubMed ID: 28656701
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin.
Kim KY; Kim SH; Yu SN; Park SK; Choi HD; Yu HS; Ji JH; Seo YK; Ahn SC
Mol Med Rep; 2015 Aug; 12(2):1898-904. PubMed ID: 25892525
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
15. Early effects of the antineoplastic agent salinomycin on mitochondrial function.
Managò A; Leanza L; Carraretto L; Sassi N; Grancara S; Quintana-Cabrera R; Trimarco V; Toninello A; Scorrano L; Trentin L; Semenzato G; Gulbins E; Zoratti M; Szabò I
Cell Death Dis; 2015 Oct; 6(10):e1930. PubMed ID: 26492365
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells.
Fuchs D; Daniel V; Sadeghi M; Opelz G; Naujokat C
Biochem Biophys Res Commun; 2010 Apr; 394(4):1098-104. PubMed ID: 20350531
[TBL] [Abstract][Full Text] [Related]
17. The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells.
Baumann P; Müller K; Mandl-Weber S; Leban J; Doblhofer R; Ammendola A; Baumgartner R; Oduncu F; Schmidmaier R
Br J Haematol; 2009 Mar; 144(6):875-86. PubMed ID: 19170678
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.
Kutuk O; Arisan ED; Tezil T; Shoshan MC; Basaga H
Carcinogenesis; 2009 Sep; 30(9):1517-27. PubMed ID: 19578044
[TBL] [Abstract][Full Text] [Related]
19. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.
Zhang Y; Liu L; Li F; Wu T; Jiang H; Jiang X; Du X; Wang Y
Biomed Res Int; 2017; 2017():4101653. PubMed ID: 28676857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
